Mental Health DailyResearch. Evidence. Perspective.Published research on Drugs.
A double-blind placebo-controlled trial found no evidence that ebselen reduced impulsivity in 130 healthy adults: 66 received ebselen, 64 received placebo, and the 1,800 mg 2-day regimen did…
Read articleA 2026 laboratory study found no detectable acute-pain increase in frequent cannabis users after at least 12 hours of biochemically verified abstinence. Frequent users had higher THC exposur…
Read articleA 2026 review in Purinergic Signalling argues that P2X7 receptors are one of the clearest molecular bridges between stress, ATP danger signaling, microglial inflammation, NLRP3 inflammasome …
Read articleA 2026 medRxiv preprint using parent-cocreated sensory-related outcome measures found that 83% of children and teens improved on at least 1 PROMIS domain during 6 months of bumetanide treatm…
Read articleA 2026 mechanistic study involving 28 healthy adults found that a single 25 mg psilocybin session changed acute brain entropy, psychological insight, well-being, cognitive flexibility, and s…
Read articleA 2026 study involving 32 adult mangrove rivulus fish pairs found that 3,000 µg/L waterborne psilocybin reduced movement and aggressive swimming bursts, but the result belongs in animal beha…
Read articlePatients with chronic insomnia frequently end up on both a sleep medication and cognitive behavioral therapy for insomnia (CBT-I), and a 2026 AASM meta-analysis of 15 RCTs from Buysse et al.…
Read article
